1. Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC). (May 2020) Authors: Sherman, Shira; Rotem, Ofer; Shochat, Tzippy; Zer, Alona; Moore, Assaf; Dudnik, Elizabeth Journal: Lung cancer Issue: Volume 143(2020) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions. Issue 8 (24th January 2020) Authors: Moore, Assaf; Den, Robert B.; Popovtzer, Aaron; Goldvaser, Hadar; Gordon, Noa; Goldstein, Daniel A. Journal: Head & neck Issue: Volume 42:Issue 8(2020) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer. (6th May 2020) Authors: Goldstein, Daniel A.; Mayer, Chen; Shochat, Tzippy; Reinhorn, Daniel; Moore, Assaf; Sarfaty, Michal; Yerushalmi, Rinat; Goldvaser, Hadar Journal: Cancer medicine Issue: Volume 9:Number 13(2020) Page Start: 4603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience. Issue 4 (24th November 2019) Authors: Moore, Assaf; Bar, Yael; Maurice‐Dror, Corinne; Ospovat, Inna; Sarfaty, Michal; Korzets, Yasmin; Goldvaser, Hadar; Gordon, Noa; Billan, Salem; Gutfeld, Orit; Popovtzer, Aron Journal: Head & neck Issue: Volume 42:Issue 4(2020) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?. Issue 25 (25th June 2021) Authors: Moore, Assaf; Bar, Yael; Maurice-Dror, Corinne; Finkel, Inbar; Goldvaser, Hadar; Dudnik, Elizabeth; Goldstein, Daniel A.; Gordon, Noa; Billan, Salem; Gutfeld, Orit; Wolf, Ido; Popovtzer, Aron Other Names: Bush. Eric section editor. Journal: Medicine Issue: Volume 100:Issue 25(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer. (December 2021) Authors: Mutai, Raz; Barkan, Tamar; Moore, Assaf; Sarfaty, Michal; Shochat, Tzippy; Yerushalmi, Rinat; Stemmer, Salomon M.; Goldvaser, Hadar Journal: Breast Issue: Volume 60(2021) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Supraglottic Carcinoma in Intravenous Opioid Drug Abusers: A Distinct Disease with Improved Survival. (18th September 2020) Authors: Yaniv, Dan; Reuven, Yonatan; Lahav, Yonatan; Cohen, Oded; Hamzany, Yaniv; Moore, Assaf; Rapana, Olga G.; Argaman, Natan; Halperin, Doron; Popovtzer, Aron; Bachar, Gideon; Shoffel‐Havakuk, Hagit Journal: Laryngoscope Issue: Volume 131:Number 4(2021) Page Start: E1190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience. Issue 11 (16th July 2020) Authors: Dagan, Or; Moore, Assaf; Nachalon, Yuval; Alkan, Uri; Biadsee, Ameen; Shochat, Isaac; Popovtzer, Aron Journal: Head & neck Issue: Volume 42:Issue 11(2020) Page Start: 3118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Cost‐Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First‐Line Intermediate‐ to Poor‐Risk Advanced Renal Cell Carcinoma. (1st February 2019) Authors: Reinhorn, Daniel; Sarfaty, Michal; Leshno, Moshe; Moore, Assaf; Neiman, Victoria; Rosenbaum, Eli; Goldstein, Daniel A. Journal: Oncologist Issue: Volume 24:Number 3(2019) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States. (2nd January 2019) Authors: Moore, Assaf; Stav, Ido; Den, Robert B.; Gordon, Noa; Sarfaty, Michal; Neiman, Victoria; Rosenbaum, Eli; Goldstein, Daniel A. Other Names: Izadpanah Reza Academic Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗